258 related articles for article (PubMed ID: 9181281)
1. Antibodies to recombinant human erythropoietin causing pure red cell aplasia.
Prabhakar SS; Muhlfelder T
Clin Nephrol; 1997 May; 47(5):331-5. PubMed ID: 9181281
[TBL] [Abstract][Full Text] [Related]
2. Immunologic mechanisms of EPO-associated pure red cell aplasia.
Schellekens H
Best Pract Res Clin Haematol; 2005; 18(3):473-80. PubMed ID: 15792922
[TBL] [Abstract][Full Text] [Related]
3. [Pure red-cell anemia due to recombinant human erythropoietin and its status in oncology practice].
Lehoczky O
Magy Onkol; 2004; 48(2):163-6. PubMed ID: 15351813
[TBL] [Abstract][Full Text] [Related]
4. Pure red cell aplasia secondary to treatment with erythropoietin.
Locatelli F; Del Vecchio L
J Nephrol; 2003; 16(4):461-6. PubMed ID: 14696747
[TBL] [Abstract][Full Text] [Related]
5. Prolonged course of pure red cell aplasia after erythropoietin therapy.
Nigg L; Schanz U; Ambühl PM; Fehr J; Bachli EB
Eur J Haematol; 2004 Nov; 73(5):376-9. PubMed ID: 15458518
[TBL] [Abstract][Full Text] [Related]
6. Pure red-cell aplasia in a peritoneal dialysis patient with HCV-related cryoglobulinemia in the absence of neutralizing antierythropoietin antibodies.
Aterini S; Fusco I; Amato M
J Nephrol; 2004; 17(5):744-6. PubMed ID: 15593045
[TBL] [Abstract][Full Text] [Related]
7. Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies.
Yang J; Joo KW; Kim YS; Ahn C; Han JS; Kim S; Lee JS
J Nephrol; 2005; 18(1):102-5. PubMed ID: 15772931
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Carson KR; Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
[TBL] [Abstract][Full Text] [Related]
9. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
[TBL] [Abstract][Full Text] [Related]
10. [Pure red cell aplasia in erythropoietin therapy in patients with kidney failure].
Opatrný K
Cas Lek Cesk; 2003; 142(12):741-5. PubMed ID: 14746223
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agents].
Rossert J; Casadevall N
Nephrol Ther; 2006 Sep; 2 Suppl 4():S283-6. PubMed ID: 17373271
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and renal failure.
Macdougall IC
Curr Hematol Rep; 2003 Nov; 2(6):459-64. PubMed ID: 14561389
[TBL] [Abstract][Full Text] [Related]
13. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
Casadevall N; Nataf J; Viron B; Kolta A; Kiladjian JJ; Martin-Dupont P; Michaud P; Papo T; Ugo V; Teyssandier I; Varet B; Mayeux P
N Engl J Med; 2002 Feb; 346(7):469-75. PubMed ID: 11844847
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating antierythropoietin antibodies in patients with end stage renal disease on regular hemodialysis.
El-Din MM; Attia FM; Labib SM; Omar W
Int J Lab Hematol; 2010 Jun; 32(3):336-43. PubMed ID: 19703235
[TBL] [Abstract][Full Text] [Related]
15. [Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].
Janda K; Kraśniak A; Krzanowski M; Sułowicz W
Przegl Lek; 2010; 67(3):187-91. PubMed ID: 20687383
[TBL] [Abstract][Full Text] [Related]
16. Pure red cell aplasia due to treatment with epoietin beta: first case report of PRCA from Poland.
Sułowicz W; Bentkowski W; Stompór T; Gross J; Biłyk A; Rudzki Z
Przegl Lek; 2006; 63(9):810-4. PubMed ID: 17479877
[TBL] [Abstract][Full Text] [Related]
17. A clinical review of antibody-mediated pure red cell aplasia.
Vogel S; Rossert J
Nephrol Nurs J; 2005; 32(1):17-8, 23-6; quiz 27. PubMed ID: 15787081
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment.
Arzouk N; Snanoudj R; Beauchamp-Nicoud A; Mourad G; Charpentier B; Tchernia G; Durrbach A
Transpl Int; 2006 Feb; 19(2):166-9. PubMed ID: 16441366
[TBL] [Abstract][Full Text] [Related]
19. High prevalence in Switzerland of pure red-cell aplasia due to anti-erythropoietin antibodies in chronic dialysis patients: report of five cases.
Schönholzer C; Keusch G; Nigg L; Robert D; Wauters JP
Nephrol Dial Transplant; 2004 Aug; 19(8):2121-5. PubMed ID: 15252171
[TBL] [Abstract][Full Text] [Related]
20. Pure red cell aplasia induced only by intravenous administration of recombinant human erythropoietin.
Shimizu H; Saitoh T; Ota F; Jimbo T; Tsukada Y; Murakami H; Nojima Y
Acta Haematol; 2011; 126(2):114-8. PubMed ID: 21654161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
